AcelRx Pharmaceuticals Inc
F:R5X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AcelRx Pharmaceuticals Inc
F:R5X
|
US |
|
Ecopro Co Ltd
KOSDAQ:086520
|
KR |
|
V
|
Versatile Creative Bhd
KLSE:VERSATL
|
MY |
|
P
|
Peptron Inc
KOSDAQ:087010
|
KR |
|
420 Property Management Inc
OTC:FTPM
|
US |
|
Triton Minerals Ltd
ASX:TON
|
AU |
|
Tokyo Century Corp
TSE:8439
|
JP |
|
Lear Corp
NYSE:LEA
|
US |
|
Akasha Wira International Tbk PT
IDX:ADES
|
ID |
|
Eramet SA
PAR:ERA
|
FR |
|
S
|
Sarawak Consolidated Industries Bhd
KLSE:SCIB
|
MY |
|
J
|
Jiangsu Tongli Risheng Machinery Co Ltd
SSE:605286
|
CN |
|
S
|
Selangor Dredging Bhd
KLSE:SDRED
|
MY |
|
Adavale Resources Ltd
ASX:ADD
|
AU |
|
North West Company Inc
TSX:NWC
|
CA |
|
Funkwerk AG
F:FEW
|
DE |
|
X
|
XPON Technologies Group Ltd
ASX:XPN
|
AU |
|
City Union Bank Ltd
NSE:CUB
|
IN |
Profitability Summary
AcelRx Pharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
AcelRx Pharmaceuticals Inc
Margins Comparison
AcelRx Pharmaceuticals Inc Competitors
| Country | Company | Market Cap |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|
| US |
A
|
AcelRx Pharmaceuticals Inc
F:R5X
|
310.3m EUR |
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
871.6B USD |
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.1B USD |
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.4B GBP |
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD |
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF |
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD |
Loading...
|
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
89.3B GBP |
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
AcelRx Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
AcelRx Pharmaceuticals Inc
F:R5X
|
310.3m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
871.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
89.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
